Clinical implication of pretreatment neutrophil to lymphocyte ratio in soft tissue sarcoma
- 7 June 2012
- journal article
- research article
- Published by Taylor & Francis in Biomarkers
- Vol. 17 (6) , 539-544
Abstract
Introduction: Elevated neutrophil to lymphocyte ratio has been identified as a prognostic indicator in malignancies whereas; its association with extremity and trunk soft tissue sarcoma remain unclear. The aim of this study is to determine the utility of full blood neutrophil lymphocyte ratio (NLR) in preoperative diagnosis and its predictive value for survival in patients managed for soft tissue sarcoma of the trunk and extremities. Method: 223 patients who presented with a soft tissue tumor were retrospectively reviewed. The study period was from January 2002–December 2009. Preoperative NLR as well as demographics, clinical and histopathological data were analysed. Results: Full blood NLR was significantly higher in patient with a soft tissue sarcoma compared to benign soft tissue tumors (p < 0.001). Cox regression analysis demonstrated that elevated NLR >5 (p < 0.05) may be an adverse prognostic factor for Overall Survival. Conclusion: The preoperative NLR is a simple, investigation predicting the preoperative diagnosis of a soft tissue sarcoma and a predictor of worse overall survival for patient with a soft tissue sarcoma.Keywords
This publication has 40 references indexed in Scilit:
- Copy Number Losses Define Subgroups of Dedifferentiated Liposarcoma with Poor Prognosis and Genomic InstabilityClinical Cancer Research, 2012
- Prognostic Impacts of Hypoxic Markers in Soft Tissue SarcomaSarcoma, 2012
- Endothelin-1 Promotes Osteosarcoma Cell Invasion and Survival against Cisplatin-induced ApoptosisClinical Orthopaedics and Related Research, 2011
- Macrophage Infiltration Predicts a Poor Prognosis for Human Ewing SarcomaThe American Journal of Pathology, 2011
- The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysisBritish Journal of Cancer, 2011
- An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome StudyBritish Journal of Cancer, 2011
- Platelet-Derived Growth Factors in Non-GIST Soft-Tissue Sarcomas Identify a Subgroup of Patients with Wide Resection Margins and Poor Disease-Specific SurvivalSarcoma, 2010
- Cancer-related inflammationNature, 2008
- Increased risk of malignancies in a population-based study of 818 soft-tissue sarcoma patientsBritish Journal of Cancer, 2006
- Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancerJournal of Surgical Oncology, 2005